• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防隐球菌病疫苗的可行性与前景

Feasibility and prospects for a vaccine to prevent cryptococcosis.

作者信息

Casadevall Arturo, Pirofski Liise-Anne

机构信息

Division of Infectious Diseases of the Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

出版信息

Med Mycol. 2005 Dec;43(8):667-80. doi: 10.1080/13693780500448230.

DOI:10.1080/13693780500448230
PMID:16422296
Abstract

Cryptococcosis is a relatively common fungal disease caused by Cryptococcus neoformans that has high morbidity and mortality. Numerous studies have established the feasibility of enhancing host immunity to C neoformans in naive immunocompetent animal models by vaccination. Several antigens have been identified that appear to be suitable vaccine candidates. Induced immune responses can mediate protection through both humoral and cellular immunity. Hence, a vaccine against cryptococcosis in humans is probably feasible but there are significant obstacles to vaccine development that range from uncertainties about the pathogenesis of infection to economic considerations.

摘要

隐球菌病是一种相对常见的真菌病,由新型隐球菌引起,具有较高的发病率和死亡率。众多研究已证实,在未感染的免疫健全动物模型中,通过接种疫苗增强宿主对新型隐球菌的免疫力是可行的。已鉴定出几种似乎适合作为疫苗候选物的抗原。诱导的免疫反应可通过体液免疫和细胞免疫介导保护作用。因此,开发针对人类隐球菌病的疫苗可能是可行的,但疫苗研发存在重大障碍,从感染发病机制的不确定性到经济因素等不一而足。

相似文献

1
Feasibility and prospects for a vaccine to prevent cryptococcosis.预防隐球菌病疫苗的可行性与前景
Med Mycol. 2005 Dec;43(8):667-80. doi: 10.1080/13693780500448230.
2
Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.用含新型隐球菌碱性提取物的葡聚糖颗粒接种后对实验性隐球菌病的保护作用。
mBio. 2015 Dec 22;6(6):e01905-15. doi: 10.1128/mBio.01905-15.
3
Vaccination with Recombinant Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species.葡聚糖颗粒中的重组蛋白疫苗以依赖于小鼠品系和隐球菌种属的方式保护小鼠免受隐球菌病的侵害。
mBio. 2017 Nov 28;8(6):e01872-17. doi: 10.1128/mBio.01872-17.
4
A Call to Arms: Quest for a Cryptococcal Vaccine.《行动呼吁:寻找隐球菌疫苗》
Trends Microbiol. 2018 May;26(5):436-446. doi: 10.1016/j.tim.2017.10.002. Epub 2017 Nov 2.
5
Glucuronoxylomannan and Sterylglucoside Are Required for Host Protection in an Animal Vaccination Model.葡聚糖醛酸木聚糖和甾基葡糖苷是动物疫苗接种模型中宿主保护所必需的。
mBio. 2019 Apr 2;10(2):e02909-18. doi: 10.1128/mBio.02909-18.
6
Towards a vaccine for Cryptococcus neoformans: principles and caveats.迈向新型隐球菌疫苗:原理与注意事项。
FEMS Yeast Res. 2006 Jun;6(4):525-36. doi: 10.1111/j.1567-1364.2006.00073.x.
7
A Heat-Killed Mutant Strain Induces Host Protection against Multiple Invasive Mycoses in a Murine Vaccine Model.热灭活突变株在小鼠疫苗模型中诱导宿主对多种侵袭性真菌感染的保护作用。
mBio. 2019 Nov 26;10(6):e02145-19. doi: 10.1128/mBio.02145-19.
8
Innate host defenses against Cryptococcus neoformans.宿主针对新型隐球菌的固有防御机制。
J Microbiol. 2016 Mar;54(3):202-11. doi: 10.1007/s12275-016-5625-7. Epub 2016 Feb 27.
9
Methodology for Anti-Cryptococcal Vaccine Development.抗隐球菌疫苗研发方法学
Methods Mol Biol. 2017;1625:129-140. doi: 10.1007/978-1-4939-7104-6_10.
10
Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.暴露于菌丝突变体后针对新型隐球菌产生保护性炎症和细胞介导免疫的过程。
mBio. 2015 Oct 6;6(5):e01433-15. doi: 10.1128/mBio.01433-15.

引用本文的文献

1
Design of an epitope-based peptide vaccine against Cryptococcus neoformans.基于表位的新型隐球菌肽疫苗的设计。
FEBS Open Bio. 2024 Sep;14(9):1471-1489. doi: 10.1002/2211-5463.13858. Epub 2024 Jul 17.
2
Epitope-Based Immunoinformatic Approach on Heat Shock 70 kDa Protein Complex of var. .基于表位的免疫信息学方法研究 var. 热休克 70kDa 蛋白复合物
J Immunol Res. 2021 Aug 19;2021:9921620. doi: 10.1155/2021/9921620. eCollection 2021.
3
A Heat-Killed Mutant Strain Induces Host Protection against Multiple Invasive Mycoses in a Murine Vaccine Model.
热灭活突变株在小鼠疫苗模型中诱导宿主对多种侵袭性真菌感染的保护作用。
mBio. 2019 Nov 26;10(6):e02145-19. doi: 10.1128/mBio.02145-19.
4
The antifungal pipeline: a reality check.抗真菌药物研发进展:现实审视。
Nat Rev Drug Discov. 2017 Sep;16(9):603-616. doi: 10.1038/nrd.2017.46. Epub 2017 May 12.
5
MyD88 Shapes Vaccine Immunity by Extrinsically Regulating Survival of CD4+ T Cells during the Contraction Phase.髓样分化因子88通过在收缩期外在调节CD4 + T细胞的存活来塑造疫苗免疫。
PLoS Pathog. 2016 Aug 19;12(8):e1005787. doi: 10.1371/journal.ppat.1005787. eCollection 2016 Aug.
6
Killed Saccharomyces cerevisiae protects against lethal challenge of Cryptococcus grubii.灭活的酿酒酵母可抵御新型隐球菌的致死性攻击。
Mycopathologia. 2014 Oct;178(3-4):189-95. doi: 10.1007/s11046-014-9798-5. Epub 2014 Aug 15.
7
HIV and co-infections.艾滋病毒及合并感染。
Immunol Rev. 2013 Jul;254(1):114-42. doi: 10.1111/imr.12063.
8
Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice.疫苗诱导的对北美地方性 3 种系统性真菌感染的保护作用需要 Th17 细胞在小鼠中发挥作用。
J Clin Invest. 2011 Feb;121(2):554-68. doi: 10.1172/JCI43984. Epub 2011 Jan 4.
9
An insight into the antifungal pipeline: selected new molecules and beyond.深入了解抗真菌药物研发管线:精选新型药物及其他药物
Nat Rev Drug Discov. 2010 Sep;9(9):719-27. doi: 10.1038/nrd3074. Epub 2010 Aug 20.
10
The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies.常见的新型隐球菌葡糖醛酸木糖甘露聚糖M2基序可引发非保护性抗体。
Vaccine. 2009 Jun 2;27(27):3513-8. doi: 10.1016/j.vaccine.2009.03.089. Epub 2009 Apr 19.